BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31313940)

  • 41. Bone marrow stroma damage induced by chemotherapy for acute lymphoblastic leukemia in children.
    Corazza F; Hermans C; Ferster A; Fondu P; Demulder A; Sariban E
    Pediatr Res; 2004 Jan; 55(1):152-8. PubMed ID: 14561785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation.
    Seriu T; Yokota S; Nakao M; Misawa S; Takaue Y; Koizumi S; Kawai S; Fujimoto T
    Leukemia; 1995 Apr; 9(4):615-23. PubMed ID: 7723394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
    Qin Y; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang JL; Yang S; Zhang CG; Dong M; Zhou LQ; Wang JW; Feng FY; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):469-73. PubMed ID: 19950562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coexistence of aberrant hematopoietic and stromal elements in myelodysplastic syndromes.
    Abbas S; Kini A; Srivastava VM; M MT; Nair SC; Abraham A; Mathews V; George B; Kumar S; Venkatraman A; Srivastava A
    Blood Cells Mol Dis; 2017 Jul; 66():37-46. PubMed ID: 28822917
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
    Uckun FM; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman GH; Gaynon PS
    Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiopoietins in the bone marrow microenvironment of acute lymphoblastic leukemia.
    Karakurt N; Aksu T; Koksal Y; Yarali N; Tunc B; Uckan-Cetinkaya D; Ozguner M
    Hematology; 2016 Jul; 21(6):325-31. PubMed ID: 26901808
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.
    Iwasa M; Miura Y; Fujishiro A; Fujii S; Sugino N; Yoshioka S; Yokota A; Hishita T; Hirai H; Andoh A; Ichinohe T; Maekawa T
    Int J Hematol; 2017 May; 105(5):587-597. PubMed ID: 28044259
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Paucity of leukemic progenitor cells in the bone marrow of pediatric B-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse.
    Uckun FM; Gaynon PS; Stram DO; Sensel MG; Sarquis MB; Lazarus KH; Willoughby M
    Clin Cancer Res; 1999 Sep; 5(9):2415-20. PubMed ID: 10499612
    [TBL] [Abstract][Full Text] [Related]  

  • 49. No evidence of increased asparagine levels in the bone marrow of patients with acute lymphoblastic leukemia during asparaginase therapy.
    Tong WH; Pieters R; Hop WC; Lanvers-Kaminsky C; Boos J; van der Sluis IM
    Pediatr Blood Cancer; 2013 Feb; 60(2):258-61. PubMed ID: 22961784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prognostic value of both detection of lymphoblasts in the period of early treatment and minimal residual disease in childhood acute lymphoblastic leukemia].
    Tie LJ; Gu LJ; Song DL; Jiang LM; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Wang YP; Chen J
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):6-9. PubMed ID: 15946500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolomics of the tumor microenvironment in pediatric acute lymphoblastic leukemia.
    Tiziani S; Kang Y; Harjanto R; Axelrod J; Piermarocchi C; Roberts W; Paternostro G
    PLoS One; 2013; 8(12):e82859. PubMed ID: 24349380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Notch Signaling in the Bone Marrow Lymphopoietic Niche.
    Sottoriva K; Pajcini KV
    Front Immunol; 2021; 12():723055. PubMed ID: 34394130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy.
    van Lochem EG; Wiegers YM; van den Beemd R; Hählen K; van Dongen JJ; Hooijkaas H
    Leukemia; 2000 Apr; 14(4):688-95. PubMed ID: 10764156
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Post chemotherapy blood and bone marrow regenerative changes in childhood acute lymphoblastic leukemia a prospective study.
    Kushwaha R; Kumar A; Aggrawal K; Nigam N; Kumar A
    Indian J Pathol Microbiol; 2014; 57(1):72-7. PubMed ID: 24739836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beta-1-integrin expression in adult acute lymphoblastic leukemia: possible relationship with the stem cell antigen CD34.
    Cacciola RR; Stagno F; Impera S; Assisi AR; Cacciola E; Guglielmo P
    Acta Haematol; 1997; 97(1-2):63-6. PubMed ID: 8980611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distinct Bone Marrow Sources of Pleiotrophin Control Hematopoietic Stem Cell Maintenance and Regeneration.
    Himburg HA; Termini CM; Schlussel L; Kan J; Li M; Zhao L; Fang T; Sasine JP; Chang VY; Chute JP
    Cell Stem Cell; 2018 Sep; 23(3):370-381.e5. PubMed ID: 30100167
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells 'hide out' in the bone marrow.
    Ratajczak MZ; Kucia M; Reca R; Majka M; Janowska-Wieczorek A; Ratajczak J
    Leukemia; 2004 Jan; 18(1):29-40. PubMed ID: 14586476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FLT3 ligand regulates thymic precursor cells and hematopoietic stem cells through interactions with CXCR4 and the marrow niche.
    Williams KM; Moore AR; Lucas PJ; Wang J; Bare CV; Gress RE
    Exp Hematol; 2017 Aug; 52():40-49. PubMed ID: 28552733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Normal and leukemic stem cell niches: insights and therapeutic opportunities.
    Schepers K; Campbell TB; Passegué E
    Cell Stem Cell; 2015 Mar; 16(3):254-67. PubMed ID: 25748932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
    Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.